GRAFT SCAFFOLD FOR CARTILAGE REPAIR AND PROCESS FOR MAKING SAME
20170348458 · 2017-12-07
Assignee
Inventors
Cpc classification
B33Y10/00
PERFORMING OPERATIONS; TRANSPORTING
B33Y30/00
PERFORMING OPERATIONS; TRANSPORTING
C08L5/00
CHEMISTRY; METALLURGY
C08L5/00
CHEMISTRY; METALLURGY
G05B19/4099
PHYSICS
B33Y80/00
PERFORMING OPERATIONS; TRANSPORTING
A61L27/3817
HUMAN NECESSITIES
B33Y70/10
PERFORMING OPERATIONS; TRANSPORTING
B33Y50/02
PERFORMING OPERATIONS; TRANSPORTING
A61L27/54
HUMAN NECESSITIES
International classification
G05B19/4099
PHYSICS
B33Y80/00
PERFORMING OPERATIONS; TRANSPORTING
B33Y70/00
PERFORMING OPERATIONS; TRANSPORTING
A61L27/54
HUMAN NECESSITIES
Abstract
The present invention relates to a method of providing a graft scaffold for cartilage repair, particularly in a human patient. The method of the invention comprising the steps of providing particles and/or fibres; providing an aqueous solution of a gelling polysaccharide; providing mammalian cells; mixing said particles and/or fibres, said aqueous solution of a gelling polysaccharide and said mammalian cells to obtain a printing mix; and depositing said printing mix in a three-dimensional form. The invention further relates to graft scaffolds and grafts obtained by the method of the invention.
Claims
1.-35. (canceled)
36. A method of providing a graft scaffold for cartilage repair, particularly in a human patient, comprising the steps of: providing an aqueous solution of a gelling polysaccharide; providing at least one of: particles and/or fibres and mammalian cells; mixing said aqueous solution of a gelling polysaccharide, said particles and/or fibres, and/or said mammalian cells to obtain a printing mix; depositing said printing mix in a three-dimensional form, wherein said gelling polysaccharide is gellan gum, acylated and/or sulfated gellan gum, and wherein said solution of a gelling polysaccharide comprises a cytocompatible polymer selected from the group consisting of alginate, alginate sulfate, gellan sulfate, carrageen, carrageen sulfate, guar gum, cassia gum, konjac gum, Arabic gum, ghatti gum, locust bean gum, xanthan gum, xanthan gum sulfate, heparin, fibrin, heparin sulfate, elastin, tropoelastin, chondroitin sulfate, dermatan sulfate, hyaluronic acid, hyaluronan sulfate, cellulose, dextran, dextran sulfate, poly-l-lysine, chitosan, silk and collagen.
37. The method of claim 36, wherein said cytocompatible polymer is alginate.
38. The method of claim 36, wherein said gelling polysaccharide is acylated gellan gum and said cytocompatible polymer is alginate.
39. The method of claim 36, wherein said aqueous solution of a gelling polysaccharide further comprises between 10 and 150 mmol/l of divalent ions.
40. The method of claim 36, wherein both mammalian cells and at least one of particles and fibres are provided for obtaining said printing mix.
41. The method of claim 36, wherein said solution of a gelling polysaccharide comprises a monosaccharide sugar or disaccharide sugar, particularly glucose, mannose or arabinose, at physiologic osmolarity.
42. The method of claim 36, wherein a growth factor and/or a mitogenic factor is provided within the printing mix.
43. The method of claim 42, wherein the growth factor and/or mitogenic factor is selected from BMP-2, BMP-7, TGF-β1, TGF-β2, TGF-β3, FGF-2, and/or IGF-1.
44. The method of claim 42, wherein the concentration of growth factors is 0.1-5 ng/ml, 5-50 ng/ml or 50-500 ng/ml.
45. The method of claim 36, wherein said mammalian cells are cartilage cells, cartilage stem cells or cartilage precursor cells.
46. The method of claim 36, wherein said mammalian cells are present at concentrations of 3×10.sup.6 cells/ml-50×10.sup.6 cells/ml.
47. The method of claim 36, wherein said printing mix comprises 10 ng/ml TGF beta 3.
48. The method of claim 36, wherein depositing said printing mix in a three-dimensional form is performed by deposition of lines of said printing mix, wherein each line has a width of 700 to 1100 μm, particularly of approx. 900 μm, and said lines overlap by 20% to 60%, particularly by 40%-50%.
49. The method of claim 36, wherein said three dimensional form is derived by 3-D-printing methods, particularly on the basis of a computer model of a contralateral organ of said patient.
50. The method of claim 36, wherein said three-dimensional form is derived by additive manufacturing methods.
51. The method of claim 50, wherein the additive manufacturing method is ink jet printing, bioprinting, extrusion printing or layer-by-layer method.
52. A graft scaffold obtainable by, or obtained by, the method of claim 36.
53. A system for running the method of claim 36, said system comprising a machine suitable for three-dimensional printing of the printing mix; and a computer programmed to run the method.
Description
[0124] The disclosure is further described with reference to the following figures and non-limiting examples, which depict particular embodiments.
[0125]
[0126]
[0127]
[0128]
[0129]
[0130]
[0131]
[0132]
[0133]
[0134]
[0135]
[0136]
[0137]
EXAMPLES
Example 1a: Bioprinting of Patient Specified Tissue Grafts
[0138] Clinical computed tomography imaging was performed and the resulting computational three-dimensional object (
[0139] Using the same technique the inventors have demonstrated the printing of several cartilaginous structures including meniscus, intervertebral discs and nose. Two-component intervertebral disc grafts could be printed with two bioink compositions mimicking the nucleus pulposus and the annulus fibrosus.
Example 1 b: Production of Cartilage Particles for Three-Dimensional Printing Purposes
[0140] Cartilage was harvested from the fresh bovine articular or auricular cartilage by removing thin layers of cartilage into a petri dish containing PBS and penicillin-streptomycin 1%. The harvested cartilage was transferred into cryomill (Retsch) and milled for three cycles in 30 Hz intensity. Milled cartilage was collected and lyophilized to obtain dry powder that could be sieved into the desired particle size range. These particles can be further loaded with growth factors or other molecules to enhance the proliferation and other cell responses. After loading the particles were lyophilyzed and cryopreserved to maximize the biomolecule availability for prolonged shelf life.
Example 1c: Printing Mix Material Preparation and the Printing Process
[0141] Printing mix material (“Bio-Ink”) was produced by combining gellan gum in 3.5% concentration with the alginate 3%. Gellan gum was dialyzed against ultrapure water to minimize the cation residues in the material. Dialysis was performed over three days in 70-80° C. ultrapure water changing the water one to two times a day. Gellan was further lyophilized to obtain a dry powder. Purified gellan gum was dissolved into glucose containing deionized water making it more cell compatible and alginate solution was added to obtain final concentration of polymers. The polymer blend was mixed with ECM particles and 6×10.sup.6 cells/ml to obtain the final printing mix material. This printing mix material stimulated the cell proliferation significantly compared to positive control (
[0142] The printing mix material was printed onto a substrate and the support polymer Pluronic F127 was co-extruded to fill subsequent layer. Pluronic contained 20 mM of SrCl.sub.2 to initiate the bioink crosslinking upon contact with the ink. Cations diffused into the printing mix material due to osmotic balance and electrostatic forces which initiated the crosslinking. Structures were generated with 410 μm needles and 800 mm/minute feedrate. Pressure applied to extrusion syringe varied between 1.2-1.4 bar. After layer-by-layer deposition of the material into desired form, the sacrificial support Pluronic was eluted in a 20 mM SrCl.sub.2 bath for few minutes before the construct was transferred to 37° C. cell culture medium.
Example 2: Bioink Composition Optimized for its Mechanical Properties and Growth Factor Retention
[0143] Bioink preparation: Gellan was added to D-glucose (300 mM) containing ultra-pure water at 90° C. to achieve a 3.5% solution, of which 85% was low-acyl gellan gum and 25% was high-acyl gellan gum. Alginate was added to the mixture to achieve 2.5% solution. The boiling flask was kept at 90° C. with agitation until the solution was homogeneous, typically for one hour. The homogeneous solution was cooled down to 30° C. prior the cell mixing. Briefly, the bovine chondrocytes (4×10.sup.6 cells/ml) were mixed in the DMEM solution and added to the bioink in culture medium in 1:10 volume ratio to pre-crosslink the bioink. Mixing was performed until the solution reached room temperature and the printing syringes were loaded.
[0144] Gellan gum high acyl (GG-HA) and low acyl (GG-LA) compositions (
Example 3: Optional Printing Material and Crosslinking Process with Support Material
[0145] Base polymer gellan 3% with additive hyaluronan conjugated with tyramine 3% were mixed together to generate enzymatically crosslinkable hydrogel in the presence of horseradisch peroxidase (HRP) and hydrogen peroxide. Materials were dissolved into deionized water in presence of monosaccharide glucose in physiologic osmolarity, specifically 300 mM. Hydroxyapatite particles in concentration of 4% (w/v) were added to the polymer mixture. This bio-ink composition was further bioprinted in the presence of HRP and hydrogen peroxide when HRP was mixed either to the bio-ink in 1 unit/ml concentration or to the pluronic F127 30% mixture together with the hydrogen peroxide in 0.0012% concentration. Layer-by-layer constructed scaffold crosslinked immediately upon contact with the support structure. The support structure was eluted in the cold medium to decrease the negative effects of hydrogen peroxide in the presence of the cells. The structure was washed several times after to minimize the amount of hydrogen peroxide residues.
Example 4: Fiber Reinforced Materials for Bioprinting
[0146] Gellan 3% was dissolved in deionized water and 10% (w/v) polymethyl metacrylate (PMMA) fibers were added as chopped eletrospun fibers into the gellan solution. Fibers were imaged with scanning electron microscopy to determine the fiber diameter to be approximately 2 micron. The fiber reinforced gellan was imaged before the shear (
Example 4a Bioink Crosslinking
[0147] An exemplary bioink is a blend of gellan and alginate mixed with human micronized Cartilage particles or HA particles 40 μm size). Upon addition of mono-, di- or trivalent cations, gelation (sol-gel transition) occurs as the helices aggregate into junction zones which are linked into a three dimensional network via the coiled part of the molecule. The printing process is divided into three stages namely bioink pre-printing, printing process and post-printing crosslinking. Initially the bioink was loaded into a syringe and the support polymer into a second syringe. At this stage, a small amount of cations were present in the bioink to increase viscosity and enhance printing properties. During the printing process the co-extruded of the support, cations diffused to the periphery of the printed structures to initiate the crosslinking. After the final structure is completed, the support can be eluted in 4° C. cation-supplemented medium.
Example 4b: Rheological Analysis
[0148] The cation related viscosity enhancement and crosslinking properties can be investigated with rheology and mechanical testing. Rheological properties of the Bioink, Bioink+HA, and Bioink+Cartilage Particles were measured with an Anton Paar MCR 301 (Anton Paar, Zofingen, Switzerland) rheometer to determine the shear behavior and shear recovery. All of the bioink compositions showed shear thinning behavior which is critical for extrusion (
TABLE-US-00001 TABLE 1 Summary of the rheological measurements. The yield points were calculated using the Herschel/Bulkley equation. Bioink + Cartilage Bioink Bioink + HA Particles Yield 15.6 Pa ± 0.7 Pa 17.7 Pa ± 6.5 Pa 122 Pa ± 22 Pa point Ces- 21% 90% 98% sation in 10 s* Max- 152 kPa ± 3.0 kPa 110 kPa ± 2.0 kPa 96 kPa ± 1.0 kPa imum G′ *Shear recovery at 10 s after the 2nd shear sequence.
[0149] The shear recovery curves (
Example 4c: Mechanical Properties and Swelling Behavior
[0150] Mechanical properties of the bioprinted cartilaginous structures were assessed in tension. Tensile dumbbell specimens were printed using Bioink+HA particles with or without cells. The nozzle path (printing direction) in the gage section of the specimen was chosen to be parallel to the direction of tension (
[0151] Swelling of the bioink with and without particles was quantified to assess the total water retention and the water retention after gel crosslinking (
Example 4d: Bioink Compatibility
[0152] Cellular bioprinting process was investigated with Bioink+HA to exclude all the interactions and proliferation cues between particles and cells. One layer thick discs were printed to assess the cell viability after printing (
[0153] The effect of cartilage particles and growth factor, in this case TGF-β3, supplementation on cell proliferation was evaluated in casted gels cultured for 21 days. The Bioink alone did not stimulate cell proliferation; in fact there was a loss in DNA at day 7 which slowly recovered. Bioink+Cartilage particles, on the other hand, stimulated proliferation and caused a statistically significant increase (p<0.001) in DNA over 21 days. With TGF-β3 supplementation, there was a statistically significant increase in DNA in the Cartilage particles containing samples at day 7 (p<0.001). By day 21, both bioinks showed increases in DNA, which were not statistically significantly from each other.
Example 4e: Extracellular Matrix Production and Cartilage Formation
[0154] Cartilage extracellular matrix production was evaluated in bioink alone and bioink+Cartilage particles with histology and immunostaining after 3 and 8 weeks in culture. Histological evaluation after 3 weeks revealed a clear increase in cell number, GAG synthesis and collagen II production in both bioink compositions supplemented with TGF-β3 (10 ng/ml). Furthermore, Bioink+Cartilage particles without growth factors stimulated cell proliferation above Bioink alone which was clearly visible with 3 and 8 week H&E staining. At both time points the Bioink+Cartilage particles showed a slight increase in Alcian blue staining and at the 8 week time point a slight collagen II staining was observed suggesting the need for additional growth factor stimulation. Cells were often seen proliferating around the particles without the growth factor supplementation which suggests that cell-particle adhesion and/or growth factors in the particles are important. However, because in the Bioink+Cartilage particles with TGF-β3 samples, no site-specific proliferation was observed, the results suggest rather the particles are a source of mitogenic growth factors and not specific cell-matrix adhesive cues. After 8 weeks, the gross appearance of the scaffolds suggested growth factor stimulation had a clear effect on cartilage matrix production as opaque appearance and increase in size was observed. At 8 weeks, both supplemented bioink compositions showed a significant increase in cartilage ECM components and had areas which began to resemble the cell density and GAG content of native cartilage. Furthermore, collagen II deposition was strong throughout the graft in the growth factor supplemented conditions while only pericellular staining was seen in the samples cultured without TGF-β3. Collagen I was found in Bioink+Cartilage particles and in both TGF-β3 supplemented conditions suggesting some fibrocartilage production, perhaps due to the passaging of the cells. In all the conditions calcification was absent suggesting the cartilage phenotype of the chondrocytes was stable.
Example 4f: Magnetic Resonance Imaging
[0155] To assess the shape retention of the printed structures several MRI techniques were evaluated. The printed nose was kept in PBS for 2 weeks to assure complete swelling prior T2-weighted MR imaging. These images were thresholded and converted into a .STL file and compared to the original model used for printing and to the cartilaginous graft immediately after printing. Comparison of the original model and the printed graft illustrates precise material extrusion and detailed structures. However, slightly thicker nostril walls were observed in comparison to the original model. Furthermore, when comparing the printed structure to the MRI model after 2 weeks swelling, a slight thickening of the nostril walls were observed, however, no sign of degradation or deterioration of the shape was detected.
Example 5: Bioprinting Process Parameters
[0156] One important factor of the reproducible printing process is the connectivity of the consecutive lines. In order to assess the effect of line spacing an optimization of line thickness must be conducted. Printing parameters such as pressure, feed rate and needle diameter were tested to standardize the line thickness to 900 μm±53 μm. After the determination of the average line thickness the effective line-line adhesion was investigated by printing a series of tensile testing dumbbells having different line spacing. The dumbbells were tensile tested until failure and the data illustrates that by increasing the line spacing the possibility of defects in the structure increased suggesting that in order to provide reproducible mechanical properties for printed structures the lines should overlap approximately 40-50%. The data suggested that the variance of the ultimate stress at failure did not differ in the tested samples with amount of overlapping lines down to 20% whereas the number of samples that were not stabile enough for testing increased with increasing line spacing. According to the data the optimal line spacing is affected by the bioink in question however by increasing the overlapping the probability of internal printing process related defects decreases. Furthermore the line thickness can be freely chosen by changing the process parameters such as pressure, printing speed and needle diameter.
[0157] Several mechanical testing measurements were performed for the newly designed bioink to investigate the parameters affecting the reproducibility of the structural and mechanical properties. The tensile evaluation of specimens printed with varying printing directions and with cell laden bioink revealed that the youngs modulus, ultimate stress and the failure strain are not altered by adding of the cells in the seeding density of 4×10.sup.6 illustrating that the volume fraction of cells (˜1% approx.) is compensated by the strong surrounding matrix. Furthermore, dumbbell specimens were printed in varying printing directions with respect to the tension, namely parallel to tension (0°), perpendicular to tension(90°) and in 45° angle to the tension (45°). The printing direction did not show any statistically significant differences between the groups suggesting that the bioprinted structures can be designed based on the printing and process related parameters rather than based on the estimated mechanical loading of the final structures.